Profile
Ara Partners is a private equity investment firm based in the United States, focusing on decarbonizing the industrial economy. The firm was founded by a team of experienced professionals with over 175 cumulative years of experience. With a nimble and flexible structure, they work closely with portfolio companies to implement change efficiently. They are distinguished by their commitment to decarbonization and by providing in-depth expertise in private equity and infrastructure investments.
They focus on a range of sectors including industrial and manufacturing, chemicals and materials, food and agriculture, and energy efficiency and green fuels. Ara Partners invests in private equity, infrastructure, and energy sectors, developing technologies that displace polluting industrial processes and supporting businesses in these fields. Their check size typically ranges from $10-50 million, targeted at growth stages across North America.
Ara Partners has made notable investments in companies like VAC, a producer of magnetic component parts for decarbonization, Genera, which invests in sustainable food systems, and USD Clean Fuels, promoting the distribution of low-carbon fuels. These investments underscore their strategy of focusing on technologies and businesses that support the transition to a net-zero economy.
Industry
Ara Partners Funds
| Name | Type |
|
|
|
Size | AUM | Launch date |
|---|---|---|---|---|---|---|---|
|
Ara Fund I, LP
|
Private Equity (PE)
|
Financial Services
Fintech
Food and Beverage
Foodtech
Transportation
Energy
CleanTech
HealthTech
|
Series B
Late Stage (Series C+)
|
North America
|
$5-10 m
|
$400 M
|
May 2020
|
|
Ara Fund III
|
Private Equity (PE)
|
Financial Services
Fintech
Food and Beverage
Foodtech
Healthcare Services
Transportation
Energy
CleanTech
HealthTech
|
Series B
Late Stage (Series C+)
|
North America
|
$5-10 m
|
$2800 M
|
December 2023
|
|
Ara Infrastructure Fund I
|
Private Equity (PE)
|
Financial Services
Fintech
Food and Beverage
Foodtech
Transportation
Energy
CleanTech
HealthTech
|
Series B
Late Stage (Series C+)
|
North America
|
$5-10 m
|
$800 M
|
May 2025
|
Contacts
Instant access on the web. Plans from $129/month — see pricing.